Published in J Med Chem on January 01, 1990
Purine nucleosides. XIV. Unsaturated furanosyl adenine nucleosides prepared via base-catalyzed elimination reactions of 2'-deoxyadenosine derivatives. J Am Chem Soc (1966) 57.26
Purine nucleosides. XII. The preparation of 2',3'-dideoxyadenosine, 2',5'-dideoxyadenosine, and 2',3',5'-trideoxyadenosine from 2'-deoxyadenosine. Biochemistry (1966) 56.84
Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science (1972) 7.74
Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin. Antimicrob Agents Chemother (1976) 6.26
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci U S A (1973) 4.36
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J Med Chem (1972) 4.12
In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother (1973) 4.04
Decreasing reliability of acid-fast smear techniques for detection of tuberculosis. Ann Intern Med (1975) 3.31
Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol (1982) 2.42
Polyamine metabolism: a potential therapeutic target in trypanosomes. Science (1980) 2.41
A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol (1976) 2.32
Bacterial studies of Clindamycin-associated colitis. A preliminary report. Gastroenterology (1975) 2.13
Refined structure of an intact IgG2a monoclonal antibody. Biochemistry (1997) 2.02
In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.97
Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med (1992) 1.89
Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice. Antimicrob Agents Chemother (1973) 1.87
Detection of pneumococci in respiratory secretions: clinical evaluation of gentamicin blood agar. J Clin Microbiol (1977) 1.83
The relationship between the metabolism of ribavirin and its proposed mechanism of action. Ann N Y Acad Sci (1977) 1.79
Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase. Antimicrob Agents Chemother (1990) 1.74
In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei. Mol Biochem Parasitol (1983) 1.69
Chemical synthesis and biological activity of 8-substituted adenosine 3',5'-cyclic monophosphate derivatives. Biochemistry (1971) 1.63
Purine nucleosides. XI. The synthesis of 2'-deoxy-9-alpha- and-beta-D-ribofuranosylpurines and the correlation of their anomeric structure with proton magnetic resonance spectra. J Am Chem Soc (1965) 1.63
Minimizing DNA recombination during long RT-PCR. J Virol Methods (1998) 1.62
Purine metabolism in Leishmania donovani and Leishmania braziliensis. Biochim Biophys Acta (1978) 1.60
The three-dimensional structure of an intact monoclonal antibody for canine lymphoma. Nature (1992) 1.57
Synthesis and antitumor activity of 2-beta-D-ribofuranosylselenazole-4- carboxamide and related derivatives. J Med Chem (1983) 1.57
Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrob Agents Chemother (1990) 1.49
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation. J Biol Chem (1979) 1.49
Cryptosporidium parvum appears to lack a plastid genome. Microbiology (2000) 1.48
A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities. Am J Trop Med Hyg (1988) 1.47
Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N Engl J Med (1977) 1.44
An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. J Parasitol (1978) 1.44
Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Antimicrob Agents Chemother (1973) 1.42
Karyotype analysis of Leishmania species and its use in classification and clinical diagnosis. Science (1986) 1.42
Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae. Mol Biochem Parasitol (1983) 1.41
Methionine recycling pathways and antimalarial drug design. Antimicrob Agents Chemother (1995) 1.40
The open conformation of a Pseudomonas lipase. Structure (1997) 1.39
Growth inhibition and induction of cellular differentiation of human myeloid leukemia cells in culture by carbamoyl congeners of ribavirin. J Med Chem (1990) 1.37
Ribozymes as human therapeutic agents. J Med Chem (1995) 1.36
Carbon-13 magnetic resonance. XVII. Pyrimidine and purine nucleosides. J Am Chem Soc (1970) 1.34
Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob Agents Chemother (1983) 1.33
Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis. Biochem Pharmacol (1985) 1.32
What is the phylogenetic position of Cryptosporidium? Int J Syst Evol Microbiol (2000) 1.29
Anaerobic infections in surgery: clinical review. Surgery (1976) 1.29
Purine metabolism in Toxoplasma gondii. J Biol Chem (1989) 1.28
Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters. J Protozool (1976) 1.27
Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc Natl Acad Sci U S A (1980) 1.26
Effect of selenazofurin on influenza A and B virus infections of mice. Antiviral Res (1986) 1.25
Reduction of "callbacks" to the ED due to discrepancies in plain radiograph interpretation. Am J Emerg Med (1998) 1.23
Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere. J Med Chem (1993) 1.23
The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro. Mol Biochem Parasitol (1989) 1.23
Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture. Cancer Res (1985) 1.22
Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor. Antimicrob Agents Chemother (1992) 1.21
Purine metabolism in the bloodstream forms of Trypanosoma gambiense and Trypanosoma rhodesiense. Biochim Biophys Acta (1982) 1.19
Effect of DL-alpha-difluoromethylornithine on methionine cycle intermediates in Trypanosoma brucei brucei. Mol Biochem Parasitol (1988) 1.19
Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi. Science (1978) 1.18
Synthesis and biochemical studies of various 8-substituted derivatives of guanosine 3',5'-cyclic phosphate, inosine 3',5'-cyclic phosphate, and xanthosine 3',5'-cyclic phosphate. Biochemistry (1973) 1.18
Optical rotatory dispersion, circular dichroism, and absorption studies on some naturally occurring ribonucleosides and related derivatives. Proc Natl Acad Sci U S A (1967) 1.17
Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother (1990) 1.17
Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine. Proc Soc Exp Biol Med (1972) 1.16
Ribavirin: an antiviral agent. Pharmacol Ther (1979) 1.16
Inducible resistance to oxidant stress in the protozoan Leishmania chagasi. J Biol Chem (2000) 1.15
Nuclear magnetic resonance determination of syn and anti conformations in pyrimidine nucleosides. J Am Chem Soc (1971) 1.14
2' Derivatives of guanosine and inosine cyclic 3',5'-phosphates. Synthesis, enzymic activity, and the effect of 8-substituents. Biochemistry (1976) 1.13
The chemistry and biological properties of nucleotides related to nucleoside 3',5'-cyclic phosphates. Adv Cyclic Nucleotide Res (1973) 1.13
Biological action of inosine analogs in Leishmania and Trypanosoma spp. Antimicrob Agents Chemother (1984) 1.11
CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect Immun (1996) 1.11
Antileishmanial effect of allopurinol. II. Relationship of adenine metabolism in Leishmania species to the action of allopurinol. J Infect Dis (1977) 1.11
Purine nucleosides. XV. The synthesis of 8-aminoand 8-substituted aminopurine nucleosides. J Org Chem (1967) 1.11
Antileishmanial effect of allopurinol. Antimicrob Agents Chemother (1974) 1.10
Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models. Am J Trop Med Hyg (1987) 1.10
Purine metabolism in Leishmania donovani amastigotes and promastigotes. Mol Biochem Parasitol (1983) 1.09
Activity of purine analogs against Leishmania tropica within human macrophages in vitro. Antimicrob Agents Chemother (1983) 1.09
5'-Alkyl-substituted analogs of 5'-methylthioadenosine as trypanocides. Antimicrob Agents Chemother (1991) 1.09
Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells. J Immunol (1993) 1.09
Carbon-13 nuclear magnetic resonance: naturally occurring nucleosides. Proc Natl Acad Sci U S A (1970) 1.08
Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms. Antimicrob Agents Chemother (1982) 1.07
Atypical mycobacteria and the xenograft valve. J Thorac Cardiovasc Surg (1978) 1.07
Purine nucleosides. XVI. Synthesis of the naturally occurring 2 -O-methylpurine ribonucleosides and related derivatives. J Am Chem Soc (1966) 1.07
Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum. Mol Biochem Parasitol (2000) 1.06
New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin. Am J Trop Med Hyg (1984) 1.06